FINWIRES · TerminalLIVE
FINWIRES

Uber Viewed as Undervalued as Investors Seek Growth, Returns, Oppenheimer Says

By

Uber Technologies (UBER) shares appear undervalued as investors look for growth, free cash flow and returns on investment, Oppenheimer said Wednesday in a report.

Uber's broad network and logistics technology offer an advantage in gaining additional market share in ride-hailing service and online food delivery, areas that still have substantial room for global expansion, the report said.

Potential near-term catalysts include expansion into new markets, improvements in freight, new transportation solutions, growth in subscription products, and progress in autonomous technology, Oppenheimer said.

Uber trades at 11 times its projected 2027 free cash flow, or 22% below peer averages, even after factoring in $1 billion of additional robotaxi capital spending, the report said.

Oppenheimer has an outperform rating on Uber stock and a $100 price target.

Price: $69.37, Change: $-1.83, Percent Change: -2.57%

Related Articles

Wire

Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Houlihan Lokey (HLI) reported fiscal Q1 adjusted earnings late Wednesday of $1.35 per diluted share, down from $2.14 a year earlier.Analysts polled by FactSet expected $1.64.Revenue in the three months ended June 30 fell to $511 million from $605 million a year earlier.Analysts expected $602.4 million.Houlihan Lokey shares fell 6.6% in after-hours trading.

$HLI
Wire

Four Corners Property Trust Q2 AFFO, Revenue Rise

Four Corners Property Trust (FCPT) reported Q2 adjusted funds from operations late Wednesday of $0.45 per diluted share, up from $0.44 a year earlier.Analysts polled by FactSet expected $0.45.Revenue in the quarter ended June 30 rose to $78.4 million from $72.8 million a year earlier.Four analysts expected $79 million.The company's shares rose 2% in after-hours trading.

$FCPT
Wire

Corcept Therapeutics Q2 Earnings, Revenue Rise; Shares Jump After Hours

Corcept Therapeutics (CORT) reported Q2 earnings late Wednesday of $0.36 per diluted share, up from $0.29 a year earlier.Analysts polled by FactSet expected $0.02.Revenue for the three months ended June 30 rose to $256.1 million from $194.4 million a year earlier.Analysts expected $221.1 million.The company boosted full-year revenue guidance to $1.1 billion to $1.2 billion from the prior forecast of $950 million to $1.05 billion.Analysts project $999.5 million.Corcept shares jumped 18% in after-hours trading.

$CORT